Free Trial

The Cigna Group (CI) Stock Forecast & Price Target

$342.21
+6.04 (+1.80%)
(As of 07/24/2024 ET)

The Cigna Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 17 Wall Street analysts who have issued ratings for The Cigna Group in the last 12 months, the stock has a consensus rating of "Buy." Out of the 17 analysts, 2 have given a hold rating, 13 have given a buy rating, and 2 have given a strong buy rating for CI.

Consensus Price Target

$376.20
9.93% Upside
High Forecast$435.00
Average Forecast$376.20
Low Forecast$330.00

According to the 17 analysts' twelve-month price targets for The Cigna Group, the average price target is $376.20. The highest price target for CI is $435.00, while the lowest price target for CI is $330.00. The average price target represents a forecasted upside of 9.93% from the current price of $342.21.

TypeCurrent Forecast
7/25/23 to 7/24/24
1 Month Ago
6/25/23 to 6/24/24
3 Months Ago
4/26/23 to 4/25/24
1 Year Ago
7/25/22 to 7/25/23
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
13 Buy rating(s)
12 Buy rating(s)
10 Buy rating(s)
8 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$376.20$374.50$362.14$333.00
Forecasted Upside9.93% Upside18.60% Upside16.98% Upside17.19% Upside
Get The Cigna Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

The Cigna Group Stock vs. The Competition

TypeThe Cigna GroupMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.72
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside9.93% Upside2,994.90% Upside10.36% Upside
News Sentiment RatingPositive News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/10/2024Cantor Fitzgerald
3 of 5 stars
S. James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$400.00 ➝ $400.00+21.44%
6/26/2024Piper Sandler
2 of 5 stars
 Initiated CoverageOverweight$400.00+18.06%
5/30/2024Baird R W
0 of 5 stars
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$432.00 ➝ $435.00+30.67%
5/30/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$388.00+16.54%
5/3/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$370.00 ➝ $400.00+18.29%
3/6/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$393.00+18.12%
3/4/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$382.00 ➝ $392.00+16.52%
2/6/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$334.00 ➝ $348.00+6.18%
2/5/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$360.00 ➝ $370.00+14.41%
2/5/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSector Perform ➝ Outperform$327.00 ➝ $354.00+9.31%
2/1/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$355.00 ➝ $370.00+22.90%
1/4/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$330.00 ➝ $372.00+22.53%
12/11/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$335.00 ➝ $341.00+31.76%
8/17/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
8/7/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$310.00 ➝ $330.00+15.15%
8/4/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$320.00 ➝ $350.00+21.48%
6/20/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$375.00 ➝ $365.00+35.77%
3/21/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight$370.00+35.58%
2/8/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$335.00 ➝ $309.00+6.92%
2/8/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$309.00 ➝ $335.00+15.92%
2/6/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$350.00 ➝ $320.00+9.35%
11/7/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$329.00 ➝ $385.00+19.52%
11/7/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$329.00 ➝ $368.00+14.24%
8/9/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$273.00 ➝ $311.00+8.48%
8/8/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$310.00 ➝ $330.00+16.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:44 AM ET.

CI Forecast - Frequently Asked Questions

What is The Cigna Group's forecast for 2024?

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for The Cigna Group is $376.20, with a high forecast of $435.00 and a low forecast of $330.00.

Should I buy or sell The Cigna Group stock right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for The Cigna Group in the last twelve months. There are currently 2 hold ratings, 13 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CI shares.

Does The Cigna Group's stock price have much upside?

According to analysts, The Cigna Group's stock has a predicted upside of 18.69% based on their 12-month stock forecasts.

Has The Cigna Group been upgraded by Wall Street analysts recently?

Over the previous 90 days, The Cigna Group's stock had 1 upgrade by analysts.

What analysts cover The Cigna Group?

The Cigna Group has been rated by research analysts at Baird R W, Cantor Fitzgerald, JPMorgan Chase & Co., Oppenheimer, Piper Sandler, and Robert W. Baird in the past 90 days.

Do Wall Street analysts like The Cigna Group more than its competitors?

Analysts like The Cigna Group more than other "medical" companies. The consensus rating for The Cigna Group is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CI compares to other companies.


This page (NYSE:CI) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners